Basic Information
AlaMab is a clinical-stage biopharmaceutical company focused on commercializing novel monoclonal antibody therapies to benefit patients with serious unmet medical needs. Founded in 2017, AlaMab is led by a highly skilled management and advisory team with extensive experience in antibody and drug development.
AlaMab Therapeutics, Inc.
Princeton,NewJersey,United States of America
unclear
January 01, 2017
--